Research on Protein-Based Nanoparticles and Their Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 93
Special Issue Editors
Interests: clinical pharmaceutics; drug delivery systems; nanoparticles
Interests: medicinal and pharmaceutical chemistry; drug discovery; biopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue focuses on protein-based nanoparticulate systems and their diverse biomedical applictations, enabling disease prevention, diagnises and therapy. Being natural, biocompatible and biodegradable, proteins have been used as an alternative to synthetic polymers to formulate nanoparticles for the targeted delivery of both therapeutic and diagnostic agents. Protein-based nanoparticles can be prepared via different green and mild nanoprecipitation methods. Various proteins, such as albumin, globulin, gelatin and gliandin, have been employed to fabricate nanoparticles for cancer treatment.
We invite researchers to submit their research articles, communications and reviews on the latest developments in the preparation, charactrisation, biological and clinical assessment of protein-based nanoparticulate systems.
Dr. Mouhamad Khoder
Dr. Hachemi Kadri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- protein
- protein derivatives
- targeted delivery
- therapeutics
- diagnostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
